B3GAT1 and head and neck cancer: Interestingly, Kinney et al. demonstrated that a subpopulation of CD57+ CD27−/CD28− T cells from head and neck cancer patients retained the ability to proliferate, indicating a highly differentiated effector memory T cell phenotype with sustained proliferative capacity.40